Article Details

Myovant Sciences and Pfizer Announce First Participant Dosed in Phase 3 SERENE Study ...

Retrieved on: 2021-04-12 10:52:30

Tags for this article:

Click the tags to see associated articles and topics

Myovant Sciences and Pfizer Announce First Participant Dosed in Phase 3 SERENE Study .... View article details on hiswai:

Excerpt

BASEL, Switzerland and NEW YORK, April 12, 2021 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV) and Pfizer Inc. (NYSE: PFE) today ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up